as the postsynaptic conductances mediated by activation of 5-HT,, receptors or a,-adrenoceptors were unaffected by the peptides. NPY/PYY act via a different mechanism than presynaptic 5-HT,, receptors. NPY/PYY probably act via presynaptic Y, receptors, as the C-terminal fragment NPY 13-36 and the Y,-selective agonist CS-NPY are effective. Since NPY and its receptors are present in the dorsal raphe nucleus, this peptide may act as an endogenous modulator of the state of activity of neurons in this region and may thus have a role in the modulation of neuronal output from this nucleus.
Neuropeptide Y (NPY) has been shown to have several neuromodulatory actions at pre-and postsynaptic sites in a number of tissues (Pemow et al., 1986 ; see other references below). In the rat hippocampus in vitro, NPY inhibits the fast (glutamatergic) synaptic potentials evoked in CA1 pyramidal neurons by stimulation of stratum radiatum. This action appears to be purely presynaptic in nature, as no evidence for postsynaptic actions of the peptide could be seen (Colmers et al., 1987 . At sympathetic neuroeffector junctions, NPY inhibits release of noradrenaline (NA), and of itself, from presynaptic sympathetic terminals (Lundberg and Tatemoto, 1982; Lundberg and Stj&ne, 1984; Lundberg and Hakfelt, 1986; Wahlestedt et al., 1990) . Here, however, it also has direct and indirect postsynaptic actions; high concentrations of NPY directly cause a contraction of smooth muscle, while subthreshold concentrations of NPY enhance contractions caused by NA or other drugs (Ekblad et al., 1984; Wahlestedt and HBkanson, 1987) . In the noradrenergic neurons of the brainstem nucleus locus coeruleus, some of which contain NPY (de Quidt and Emson, 1986 ), NPY appears to potentiate postsynaptic responses to cu,-adrenoceptor activation; it is not known whether there are any effects on synaptic potentials evoked in this nucleus (Illes and Regenold, 1990 ). NPY's actions therefore vary with the system, presumably to elicit an appropriate, coordinated response to the higher levels of stimulation thought to cause preferential release of peptides (Bartfai et al., 1988) .
The dorsal raphe (DR) nucleus is a brainstem nucleus composed mainly of 5-HT-secreting neurons that project rostrally to supply the serotonergic innervation of the forebrain (And& et al., 1966; Azmitia and Segal, 1978; Fuxe and Jonsson, 1984; Tork, 1987, 1988; Aitken and Tork, 1988) . These cells receive a variety of synaptic inputs, including fast responses mediated by the amino acids glutamate and GABA (Kalen et al., 1985 (Kalen et al., , 1986 Pan and Williams, 1989a) , and slower potentials mediated by 5-HT (Chazal and Rahlston, 1987; Williams et al., 1988) and NA (Aghajanian and Wang, 1977; . The pharmacology of these synaptic responses has been well characterized (Baraban and Aghajanian, 1980; Yoshimura andHigashi, 1985; Yoshimuraetal., 1985; Williamsetal., 1988; Pan and Williams, 1989a,b; Bobker and Williams, 1990) . In addition, DR neurons are relatively compact electrically, permitting acceptable single-electrode voltage clamp of slow membrane conductances with conventional sharp electrodes. NPY is present in moderately high concentrations in DR (O'Donoghue et al., 1985) , and NPY binding sites are concentrated there (Saria et al., 1985; Martel et al., 1990 ). The DR is therefore a good system in which to test the hypothesis that NPY acts at presynaptic sites to regulate synaptic transmission. The results indicate that NPY and related peptides selectively inhibit slow synaptic responses mediated by 5-HT and NA, by an action at a presynaptic site, while not affecting the rapid synaptic responses mediated by amino acid release. The peptide could, by its combined presynaptic actions, induce a change in state of the DR neurons similar to that induced in hippocampal pyramidal neurons by the postsynaptic action of NA.
Materials and Methods
In vitro slicepreparation. Methods used were essentially similar to those reported earlier (Williams et al., 1988) . Briefly, male Sprague-Dawley rats (200-350 gm) were lightly anesthetized with halothane and killed by a heavy blow to the spinal cord. The brain was then quickly removed and placed in ice-cold, carbogenated (95% 0,, 5Oh CO,), artificial cerebrospinal fluid (ACSF, pH 7.35). Coronal sections (350 pm thick) were then cut with a vibratome from a block of tissue containing caudal regions of the DR nucleus in cold (4°C) carbogenated ACSF. The slices were immediately placed in a solution of carbogenated ACSF and incubated at 34°C for a minimum of 1 hr. A slice containing caudal regions of the DR was then transferred to a recording chamber where it was submerged and continuously superfused at a rate of 2.5-3 ml/min with carbogenated ACSF, which-had been prewarmed to 34 + 0.2"C. The comnosition of the ACSF was fin mM) NaCl. 126: KCl. 2.5: NaH,PO,. 1.2; MgCl,, 1.2; CaCl,, 2.4; &glucose, 11: NaHCO, 25: To evoke synaptic potentials, a bipolar tungsten stimulating electrode, connected to a stimulus isolating unit, was placed in, or adjacent to, the DR.
Intracellular recording. Neurons were impaled with glass microelectrodes filled with 2 M KC1 (50-120 Mfi), connected to the headstage of an Axoclamp 2A amplifier. Only neurons with the characteristic complex synaptic responses, and that responded to the application of the 5-HT, agonist 5-carboxamidotryptamine (5-CT) with an inwardly rectifying potassium conductance, were studied. Synaptic potentials were recorded in bridge current-clamp mode upon stimulation via the bipolar electrode. Stimuli (1 MO V, l-2 msec) were presented either singly or in pairs (interstimulus interval, 20 msec). In the presence of neurotransmitter agonists, current ofthe appropriate sign was applied to the neuron via the balanced bridge circuit to keep it at the original membrane potential (l',,,). The fast, amino acid-dependent, depolarizing synaptic potentials (DSPs; Pan and Williams, 1989a) were blocked with a cocktail containing 10 PM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 50 PM m-2-amino-5-phosphonovaleric acid (APV), and 50 PM picrotoxin. Slow EPSPs (sEPSPs) were blocked with prazosin (100 nM), and IPSPs were blocked with cyanopindolol (1 PM), or reduced with m-trifluoromethylphenylpiperazine (TFMPP, 1 PM). For voltage-clamp experiments, the discontinuous single-electrode voltage-clamp technique (switching frequency, 3.4-4.2 kHz) was used; electrodes were coated with Sylgard (Dow-Coming) to reduce capacitance. Headstage voltage was continuously monitored to ensure proper voltage clamp; headstage voltage pulses had to be square, and electrode settling after the current passing phase had to be complete prior to voltage sampling for the clamp to be considered acceptable. Neurons were routinely held near their resting membrane potential at -60 mV (I'*). For ramp experiments, the voltage was slowly (2 set) ramped from -60 mV to -125 mV and then held for 2 set to stabilize the membrane before ramping gradually (-20 set) to -40 mV. In a few experiments, the voltage was ramped from -115 mV to -40 mV. Ramps were digital averages of two successive responses taken 30 set apart. In some experiments, voltage steps of 1 set duration were applied to potentials both negative and positive to Vn. Data were corrected for any electrode offset observed at the end of an experiment. Digital averages of three successive synaptic responses, taken at 60 set intervals, were used for figures and for data analysis. The maximum amplitude of each synaptic response was taken as the magnitude of that response.
All data were stored on computer for on-line analysis using the ~CLAMP program (Axon Instruments) or digitally on videotape for playback and off-line analysis using a Nicolet 4094 digital oscilloscope. Current and voltage data were recorded continuously during an experiment with a pen recorder (Gould Brush 2200). For some figures, current records were digitally subtracted using AXUM software (TriMetrix, Seattle, WA). Data are expressed as percentage inhibition of control values; averages are presented as means f SEM. Preparations served as their own controls; all data are from preparations that showed significant recovery upon washout. Statistical comparisons were performed using a Student's t test. Statistical differences were considered significant at p IS 0.05.
Drugs were dissolved in warmed, carbogenated ACSF just prior to use and applied via bath perfusion. NPY, peptide YY (PYY), and NPY 13-36 were obtained from INRS, Pointe-Claire, Quebec, and dissolved in ACSF in a final volume of 10 ml mior to use. CZ-NPY was a gift of Dr. J. L. Krstenansky (Metrell Dow). -Cyanopindolol was a gift of Sandoz (Canada). TFMPP was obtained from RBI (Natick, MA). All other drugs were obtained from Sigma (St. Louis, MO). 1989a,b), as well as to antagonists of the GABA, receptors (the intracellular electrodes used in these experiments contained KCl, which shifted the chloride equilibrium potential positive to rest, thus producing a depolarizing response; Williams et al., 1988 Figure 2 . NPY and PYY have no effect on amino acid-mediated synaptic responses in the rat DR nucleus. Superimposed are the DSP evoked in control and in the presence of NPY (1 PM). NPY has no effect on the DSP, while it inhibits the IPSP.
followed by a sEPSP, mediated by a,-adrenoceptors Pan and Williams, 1989) . Bath application of 1 PM NPY caused a reduction both in the IPSP (by 33.3 f 4.4%; n = 10, p < O.OOOl), and the sEPSP (by 40.2 f 7.8%; n = 11, p < 0.00 1; Fig. lb ). This inhibition was slow (5-10 min) in onset and reversed upon prolonged washout (Fig. 1 c) . All data reported are from preparations demonstrating substantial (> 90%) recovery from peptide effect. The NPY analog, PYY (1 PM), which shares 70% sequence homology with, and a high degree of analogy to, NPY (Tatemoto, 1982) , also reversibly inhibited the IPSP by 45.4 f 4.0% (n = 9, p < 0.00 l), and the sEPSP by 31.2 f 6.0% (n = 6, p < 0.005) (Fig. Id) . Because the effects of NPY and PYY on slow synaptic responses were statistically indistinguishable, they were used interchangably in all following experiments. By contrast, neither NPY nor PYY had an effect on the fast synaptic component (n = 11, p > 0.5; Fig. 2 ).
NPYIPYY inhibit isolated slow synaptic responses To determine if the slow components of the complex synaptic response were modulated individually, we isolated the slow synaptic responses by pharmacological means and then studied the effect of NPY/PYY. The DSP was blocked with a cocktail containing supramaximal concentrations of antagonists to quisqualate/kainate and NMDA receptors and a GABA, (chloride) channel blocker (Pan and Williams, 1989a ; see Materials and Methods). Additionally, the sEPSP was completely eliminated in the presence of 100 nM prazosin, a selective a,-adrenoceptor antagonist Williams, 1989b, Bobker and Williams, 1990b) . PYY reduced the resulting isolated IPSP by 22.0 & 4.2% (n = 3, p < 0.025; Fig. 3a) , indicating that the IPSP inhibition was direct.
Because the 5-HT,, antagonist spiperone also blocks cy,-adrenoceptors (Pan and Williams, 1989a) , we explored other pharmacological means of isolating the sEPSP. Blockade of both 5-HT,, and 5-HT,, receptors with 1 MM cyanopindolol (Bobker and Williams, 1990b) in the presence of the amino acid antagonist cocktail completely isolated the sEPSP. In the presence of cyanopindolol, PYY reversibly inhibited the sEPSP by 35.0 f 8.6% (n = 3, p < 0.025; Fig. 3b ).
To determine whether inhibition of the IPSP by NPY/PYY receptors occurred via the same mechanism as the presynaptic 5-HT,, receptor that inhibits release of 5-HT in DR (Bobker and Williams, 1990a TFMPP caused an inhibition of evoked, 5-HT-mediated responses (Bobker and Williams, 1990a,b) , reducing the IPSP by 61.7 f 9.8% (n = 5). The IPSP remaining after TFMPP treatment was reversibly reduced by PYY (by 36.3 + 6.1%; n = 4, p < 0.01; Fig. 3~ ). As well, PYY reduced the sEPSP in the presence of TFMPP (and the amino acid antagonist cocktail) by 21.5 f 4.2% (n = 3, p < 0.025; not illustrated).
NPYIPYY have no effect on postsynaptic conductances To determine the locus of the peptides' action on synaptic responses, we applied single-microelectrode voltage clamp to DR neurons (Finkel and Redman, 1984; Williams et al., 1988; Pan and Williams, 1989) to test whether the peptides affected voltage and ligand-induced conductances. Application of 1 PM NPY or PYY alone did not affect the resting membrane conductance of DR neurons, nor did it affect steady-state voltage-dependent conductances elicited by a slow (= 20 set), steady voltage ramp from -115 to -40 mV. At the same time, the slow synaptic potentials were inhibited (Fig. 4) . Having seen no effect on resting membrane conductances, we next determined whether the peptides modulated ligand-induced conductances, as has been postulated for NPY in locus coeruleus neurons (Illes and Regenold, 1990) . Selective agonists were applied to activate either the postsynaptic 5-HT receptors or (Y, -adrenoceptors; we then examined whether coapplication of the peptide altered the ligand-induced changes in membrane conductance, while at the same time examining the effects of the peptides on synaptic potentials.
Application of 100 n.~ 5-CT, a full agonist at the postsynaptic 5-HT,, receptors (Hoyer, 1988; Williams et al., 1988; Pan et al., 1989; Andrade and Chaput, 199 l) , hyperpolarized DR neurons in current clamp (Williams et al., 1988) . This was accompanied by a marked reduction of the IPSP, the sEPSP was shortened but not greatly reduced in amplitude (Fig. 5aJ . When the cells were held near rest in voltage clamp ( V, = -65 mv), 5-CT elicited an outward current, which rectified inwardly (Fig. 5aJ as previously reported (Williams et al., 1988) . Voltage step commands (1 set) were also applied to different potentials (Fig. 5~~) ; no significant differences were observed in current values measured at the end of a 1 set voltage step and during the slow voltage ramp (Fig. 5a,) , indicating that the ramp measured steadystate membrane conductances (Williams et al., 1988) . Application of PYY (1 PM) in the presence of 5-CT had no effect on the time-dependent (Fig. 5b,,,) or steady-state membrane con- Figure 4 . Inset a,, the synaptic potentials, evoked at the same membrane potential in control and in the presence of PE. The neuron was hyperpolarized to the control potential for comparison of synaptic potentials. The sEPSP is occluded by the application of PE. Inset a,, Digital subtraction of the steady-state Z-V curves in a,. Zr, Steady state Z-V curves in PE (V), and in PE with 1 PM PYY m. Insets as in a. Although PYY has no effect on the membrane currents, the IPSP evoked in current clamp is inhibited.
ductances (Fig. 5b,,,) over the voltage range examined. However, ylephrine (PE, 1 PM; Baraban and Aghajanian, 1989 ) induced the sEPSP recorded in current clamp was reversibly inhibited a steady-state inward current near rest (Fig. 6a ,,& as well as by 37.95 f 7.2% (n = 5, p < 0.005; Fig. 5bJ .
appearing to reduce an outward current in the depolarizing reIn analogous experiments, the a,-adrenoceptor agonist phengion of the current-voltage relationship (Fig. ~cz, liams, 1989), corresponding to a depolarization in current clamp; the sEPSP was also occluded (Fig. 6a2) . Application of PYY (1 FM) did not significantly alter the steady-state membrane conductance in the presence of PE (Fig. Sb,. ,), but the isolated IPSP, recorded in current clamp, was inhibited by 3 1 .O + 9.9% (n = 4, p < 0.005; Fig. 6bJ .
Synaptic effects of NPYIPYY are mimicked by Y, receptor agonist Two receptors for NPY/PYY have been identified, which can be differentiated on the basis of agonist fragments of NPY or PYY. The Y, receptors require the entire, intact peptide, while the Y, receptors can be activated by amidated C-terminal peptide fragments as short as NPY 13-36 (Wahlestedt et al., 1986) . Because presynaptic inhibition mediated by NPY at peripheral (Wahlestedt et al., 1986) and central mammalian synapses (Colmers et al., 1991) has been shown to be mediated by Y, receptors, we examined the effect of NPY 13-36 on slow synaptic responses in DR to determine whether this effect was also mediated by a Y, receptor. A 1 PM concentration of NPY 13-36 reversibly inhibited IPSP and sEPSP by 15.88 + 1% (n = 3, p < 0.005) and 26.58 f 10.82% (n = 2, p < 0.25), respectively (Fig. 7a) . Although the inhibition of the sEPSP was not statistically significant, NPY 13-36 clearly demonstrated a reversible inhibition of this response.
To examine further the question of receptor subtype, we examined whether the recently developed Y, receptor ligand [Cys2, 8-aminooctanoic acid5J4, D-C~@NPY (C2-NPY, MDL 29,6 16; McLean et al., 1990 ) affected slow synaptic potentials in DR. Application of C2-NPY (1 PM) inhibited the IPSP by 33.2 f 0.5% (n = 2, p < O.Ol), and the sEPSP by 47.1 f 0.8% (n = 2, p < 0.01; Fig. 7b ). The inhibition of both slow synaptic potentials by C2-NPY was reversible (not illustrated).
Discussion
In this study, we have demonstrated that NPY and PYY inhibit both hyperpolarizing and depolarizing slow synaptic potentials in DR, while not measurably affecting the fast synaptic potentials. This observation is in contrast to their previously reported effect in the hippocampus (Colmers et al., 1987 (Colmers et al., , 1991 . These actions are presynaptic since there was no effect on resting, voltage-activated, or agonist-induced membrane conductances. As well, there was no effect on the fast, amino acid-mediated synaptic responses, consistent with a selective presynaptic action at serotonergic and noradrenergic terminals alone.
The actions of NPY/PYY are mimicked consistently, though less potently, by the carboxy-terminal NPY 13-36 fragment. The Y, receptor-selective ligand C2-NPY is an agonist as well. These data suggest that the actions of NPY/PYY may be mediated by the activation of a presynaptic Y, receptor, as has already been demonstrated in the hippocampus (Colmers et al., I99 1) and elsewhere (Wahlestedt et al., 1986) . In most systems, the agonist fragment is less potent than the intact peptide; in rat hippocampus NPY 13-36 is about 50% as potent as NPY (Colmers et al., 199 1) . Interestingly, the peptidergic inhibition of the IPSP was reduced after blockade of cu,-adrenoceptors, suggesting that a portion of the IPSP was facilitated by noradrenergic excitation of neighboring DR neurons.
Although this study did not address in detail the mechanism of presynaptic action by NPY/PYY, it seems clear that the peptidergic inhibition of the IPSP appears to be independent of the presynaptic 5-HT,, receptor and its mechanism of action, as PYY inhibited the IPSP remaining after a supramaximal concentration of the 5-HT,, agonist TFMPP was applied. There is evidence in hippocampus and in cultured dorsal root ganglion neurons (Bleakman et al., 199 1) that Y, receptors inhibit Ca 2+ influx. However, the mechanism of Y, presynaptic action in DR will need to be elucidated in detail, perhaps aided by the likelihood that there are two presynaptic mechanisms by which the IPSP can be inhibited.
The present results indicate that NPY and PYY modulate slow synaptic transmission in DR by a presynaptic mechanism. This means that at central, as well as peripheral, synapses (Wahlestedt et al., 1986 ) NPY can inhibit the release of NA. The observed inhibition by NPY of a 5-HT-induced synaptic response (probably through inhibition of release) is a novel finding. Data from microdialysis of hypothalamic nuclei with NPY show a reduction in levels of NA, 5-HT, and their metabolites (Shimizu and Bray, 1989) , suggesting a presynaptic inhibitory action, as we have observed here. Although NPY has been reported to modulate the NA response of the locus coeruleus neurons via a postsynaptic mechanism (Illes and Regenold, 1990) , we observed no such interaction in the DR.
The inhibition by NPY of both slow inhibitory and excitatory synaptic inputs to DR neurons appears contradictory. There is, however, a potential explanation for this apparent contradiction. Noradrenergic tone is required for the tonic activity of DR neurons observed in vivo (Baraban and Aghajanian, 1980) . Release of NPY onto its receptors in DR would be expected to reduce this activity. At the same time, NPY would be expected to reduce the 5-HT,, receptor-mediated inhibition of the DR 5-HT cells. Because the action of NPY is entirely presynaptic, other mediating or modulating influences on the postsynaptic membrane will remain unaltered. We suggest that the release of NPY could therefore induce a state of "quiet readiness" in DR neurons, where the tonic level of activity is lowered, but that the response to suprathreshold stimuli (such as from the habenular excitatory amino acid inputs; Ralen et al., 1985 Ralen et al., , 1986 will be enhanced, because the activity-dependent autoinhibition, caused by the release of SHT, is attenuated. A similar change of state is induced by NA in hippocampal pyramidal neurons, albeit by a postsynaptic mechanism (Madison and Ni-~011, 1982) .
